title: Severe myelosuppression and MRSA infection as the presentation of perinatal HIV infection.
authors.forename: Eileen J
authors.initials: EJ
authors.lastname: Rhee
authors.forename: Carey
authors.initials: C
authors.lastname: Linden
authors.forename: Amos
authors.initials: A
authors.lastname: Adler
authors.forename: Jennifer
authors.initials: J
authors.lastname: Burns
authors.forename: John
authors.initials: J
authors.lastname: Marcinak
mesh_terms: D000038:Abscess / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D019380:Anti-HIV Agents / Q000008:administration & dosage; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000151:congenital* / Q000188:drug therapy; D006801:Humans; D007223:Infant; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D010198:Pancytopenia / Q000175:diagnosis* / Q000473:pathology; D013207:Staphylococcal Skin Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology
chemical_list: D000900:Anti-Bacterial Agents; D019380:Anti-HIV Agents